The humoral adaptive immune response, a cornerstone of immunological memory and pathogen defense, is orchestrated by the vast and dynamic population of B lymphocytes. Central to this process is the clonal selection theory, which posits that upon encountering a cognate antigen, a specific B cell is selected for proliferation and differentiation. This process generates a population of cells, or a "clone," derived from a single progenitor, whose B-cell receptors (BCRs) have been refined through somatic hypermutation (SHM) to achieve higher antigen-binding affinity. The collective BCR sequences within an individual—the BCR repertoire—thus serve as a molecular ledger of past and ongoing immune responses.
Identify B Cell Clones with Confidence. .
| Condition | BCR Repertoire Feature | Implication |
| Healthy individuals | High clonal diversity | Broad readiness to respond to diverse antigens |
| Pathological states | Marked clonal dominance (few clones proliferate excessively) | Reduced diversity, potential malignancy or autoreactivity |
Analyzing the clonal architecture of the BCR repertoire provides profound insights into the state of the immune system.
Sensitivity vs. Specificity Trade-off
Computational Inefficiency
To address these critical gaps, a robust, sensitive, and computationally efficient solution is required to accurately delineate the clonal landscape of the B-cell repertoire.
Turn Complex Repertoire Data into Clear Insights. .
At Creative Biolabs, we have engineered an integrated, end-to-end platform specifically optimized for high-fidelity BCR repertoire analysis. Our platform combines state-of-the-art molecular biology techniques with a proprietary high-throughput sequencing and bioinformatics pipeline, designed to deliver unparalleled accuracy and depth in B-cell clone identification.
Our sequencing infrastructure is designed to handle large-scale projects, accommodating numerous samples simultaneously without compromising data quality. This enables comprehensive cohort studies and longitudinal monitoring of immune responses.
We provide exceptional sequencing depth, ensuring the capture of both dominant and rare B-cell clones. This high resolution is critical for detecting minimal residual disease in cancer patients or identifying nascent pathogenic clones in autoimmune disorders.
Through rigorous quality control at every stage—from sample intake to final data delivery—we ensure high-accuracy sequence reads, minimizing the impact of PCR and sequencing artifacts on downstream clonal analysis.
The platform is supported by a powerful, scalable computational backend capable of processing millions of BCR sequences with remarkable efficiency. Our proprietary algorithms are tailored to provide the most accurate clonal partitioning available.
Discover the True Clonal Landscape of B Cells. .
Our BCR Repertoire Profiling Service for B Cell Clone Identification is a comprehensive solution that guides researchers from raw biological samples to actionable immunological insights.
The process begins with the expert preparation of BCR sequencing libraries from client-provided samples, such as peripheral blood mononuclear cells (PBMCs) or B cells isolated from tissues. Our proprietary protocols are designed to specifically amplify BCR variable regions, ensuring complete coverage of the key hypervariable domains, including the crucial junction region, which is essential for accurate clone identification. This step is optimized to prevent amplification bias and preserve the natural clonal distributions within the sample.
From Data to Discovery — .
The data and analyses generated by our service provide a powerful foundation for a wide spectrum of research and clinical investigations. Beyond the fundamental task of B-cell clone identification, our service supports a multitude of advanced applications:
By analyzing polymorphisms across the vast number of BCR sequences, our platform can identify previously unannotated Ig V-segment alleles, contributing to the expansion of public immunoglobulin gene databases and refining our understanding of germline diversity.
By comparing sequences within an identified clone, researchers can meticulously map the patterns of SHM. This allows for the investigation of mutational hotspots, the influence of local sequence context on mutability, and the mechanistic underpinnings of B-cell affinity maturation.
Our service is a critical tool for translational medicine. In oncology, it can be used to identify tumor-specific B-cell clones, monitor clonal evolution in response to immunotherapy, or track minimal residual disease. In autoimmunity, it enables the characterization of pathogenic, self-reactive B-cell clones and the assessment of therapeutic interventions aimed at restoring immune tolerance.
We have broken the barrier of human-centric analysis. Our service supports BCR repertoire profiling across a diverse range of species, including but not limited to feline, zebrafish, alpaca, canine, rabbit, and swine. This capability is invaluable for comparative immunology studies, animal model development for human diseases, and veterinary medicine research.
Uncover Hidden Patterns in BCR Repertoires. .
Our BCR Repertoire Profiling Service is distinguished by a suite of advantages designed to address the core challenges in the field and deliver superior value to our clients.

Overcomes the low sensitivity and specificity of conventional approaches, preventing both false negatives and false positives in clone identification.

Alleviates challenges in sample acquisition, making the service ideal for rare clinical specimens and longitudinal studies with limited material.

Guarantees the reliability and reproducibility of results, allowing for direct use in scientific publications and clinical-grade analyses.

Eliminates the risk of erroneous conclusions drawn from non-expert analysis and provides clients with in-depth data interpretation and consultation.

Reduces the financial and logistical burden on research institutions, particularly small to medium-sized labs, enabling access to cutting-edge technology.
Accelerate Your Immunology Research. .
Your Breakthrough in B Cell Research Starts Here. .
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.